These analyses identified a widespread disruption in several biological pathways already known to be involved in the postnatal pathogenesis of SMA, including cell cycle regulation (29, 30), cytoskeleton signaling pathway (31–33), and p53 signaling (34, 35). The gene discussed is TP53; the disease is proximal spinal muscular atrophy.